Patents
Patents for C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
09/2013
09/11/2013EP2635586A1 Method for the manufacturing of naltrexone
09/11/2013EP2635107A1 Papaver bracteatum with modified alkaloid content
09/11/2013CN103298819A Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
09/10/2013US8530495 Nalmefene hydrochloride dihydrate
09/10/2013US8530494 Buprenophine analogs
09/05/2013US20130231485 Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same
09/03/2013US8524904 Process for the preparation of 6-alpha-hydroxy-N-alkylated opiates
08/2013
08/28/2013EP2630150A2 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain
08/27/2013US8519133 Preparation of 6-alpha-amino N-substituted morphinans by catalytic hydrogen transfer
08/21/2013CN103261203A 6-amido derivatives of 4,5a-poxymorphinans for treatment of pain
08/21/2013CN103257189A (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use
08/20/2013CA2579378C Treatment of diseases using nalmefene and its analogs
08/15/2013WO2013119886A1 One pot process for producing 6-hydroxyl nal-opiate
08/15/2013US20130210854 Compositions Comprising Enzyme-Cleavable Prodrugs of Active Agents and Inhibitors Thereof
08/13/2013CA2393141C Novel methods for the treatment and prevention of ileus
08/08/2013WO2013113120A1 Process for the preparation of morphine analogs via the reaction of organometallic reagents with an oxazolidine derived from morphinans
08/08/2013WO2013093931A3 Novel prodrugs of phenolic drugs
08/08/2013US20130205452 Papaver somniferum with high concentration of codeine
08/08/2013US20130203999 One Pot Process for Producing 6-Hydroxyl Nal-Opiate
08/08/2013US20130203797 Therapeutic or prophylactic agent for biliary diseases
08/07/2013EP2621496A1 Crystalline naloxol-peg conjugate
08/07/2013CN103237804A Method for the manufacturing of naltrexone
07/2013
07/31/2013EP2619212A1 Buprenorphine analogs
07/23/2013US8492547 Method for the enrichment of buprenorphine using chromatographic techniques
07/18/2013WO2013106528A1 Bivalent ligands for the treatment of neurological disorders
07/17/2013CN103204859A Nalmefene hydrochloride compound and preparation method thereof
07/09/2013US8481501 Synthesis of metabolically stable analgesics, pain medications and other agents
06/2013
06/27/2013WO2013095321A1 Heroin haptens, immunoconjugates and related uses
06/26/2013CN103172640A Preparation method of (R)-N-bromine-methyl naltrexone and naltrexone derivatives
06/25/2013US8471022 Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone
06/20/2013US20130158061 Controlled release hydrocodone
06/13/2013WO2013084060A1 Quaternized buprenorphine analogs
06/13/2013WO2013083685A1 Process for recovery of nalmefene hydrochloride
06/13/2013US20130150395 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
06/13/2013CA2857096A1 Process for recovery of nalmefene hydrochloride
06/12/2013EP2601196A1 N-demethylation of 6-keto morphinans
06/12/2013EP2601195A1 Tandem process for preparing n-alkyl morphinans
06/12/2013CN103154000A Buprenorphine analogs
06/12/2013CN101827819B Quaternary opioid carboxamides
06/11/2013US8461122 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/04/2013US8455644 Peripheral opioid receptor antagonists and uses thereof
06/04/2013US8455509 Method for the preparation of morphine compounds
05/2013
05/22/2013EP2593095A1 (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
05/22/2013CN103113378A Synthesis method of oxymorphone hydrochloride
05/21/2013CA2555215C Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
05/15/2013EP2590649A1 Process for the synthesis of substituted morphinans
05/14/2013US8440687 Oligomer-opioid agonist conjugates
05/14/2013US8440686 Nalmefene prodrugs
05/14/2013US8440634 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
05/08/2013EP2588481A1 Process for the synthesis and purification of oxycodone
05/07/2013US8436175 Carboxamide bioisosteres of opiates
05/07/2013CA2744932C Nalmefene hydrochloride dihydrate
05/02/2013WO2013063204A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
05/02/2013CA2856608A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
04/2013
04/30/2013US8431701 Process for the reductive alkylation of normorphinans
04/25/2013US20130102784 Process for n-dealkylation of tertiary amines
04/25/2013US20130102780 Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
04/24/2013CN1653050B Opioid and opioid-like compounds and uses thereof
04/17/2013EP2580218A1 Process for n-dealkylation of tertiary amines
04/17/2013CN102166432B Method for extracting morphine from opium
04/16/2013CA2486157C Opioid and opioid-like compounds and uses thereof
04/11/2013WO2013050748A2 An improved method of preparing buprenorphine
04/11/2013US20130089504 Compositions Comprising Enzyme-Cleavable Hydromorphone Prodrug
04/11/2013CA2849988A1 Process for preparing buprenorphine
04/03/2013CN103012416A Method for preparing high-purity nalmefene hydrochloride
04/03/2013CN101607963B Morphinan derivatives and preparation method thereof
04/03/2013CN101228172B 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
04/02/2013CA2702032C Skin property-improving therapeutic agent comprising a morphinan derivative or any of its pharmacologically permissible acid addition salts as an active ingredient
03/2013
03/28/2013US20130079364 Peripheral Opioid Agonists and Peripheral Opioid Antagonists
03/26/2013US8404706 Opioid and opioid-like compounds and uses thereof
03/26/2013CA2539659C Process for the synthesis of morphinane compounds and intermediates thereof
03/19/2013US8399671 Methods for producing hydrocodone, hydromorphone or a derivative thereof
03/19/2013US8399475 Crystalline and amorphous forms of naltrexone hydrochloride
03/14/2013WO2013036729A1 Production of alkaloids without the isolation of intermediates
03/14/2013US20130066080 Production of Alkaloids without the Isolation of Intermediates
03/14/2013CA2845187A1 Production of alkaloids without the isolation of intermediates
03/12/2013US8394813 Active agent delivery systems and methods for protecting and administering active agents
03/06/2013EP2563793A1 Preparation of saturated ketone morphinan compounds having low metal content
03/05/2013US8389540 Polymorphic solvates of naltrexone with ethanol, benzyl alcohol, dimethylformamide, methanol, dichloromethane, acetone and hexane; sustained release formulations
02/2013
02/27/2013EP2562177A2 Transdermally deliverable buprenorphine prodrugs and abuse-resistant compositions thereof
02/27/2013CN102942572A Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof
02/26/2013US8383815 Heterogeneous ruthenium metal catalyst for the production of hydrocodone, hydromorphone or a derivative thereof
02/26/2013CA2638195C Process for the preparation of quaternary n-alkyl morphin or morphinan alkaloid derivatives
02/21/2013US20130045960 Abuse-Deterrent Pharmaceutical Compositions of Opiods and Other Drugs
02/21/2013US20130045165 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators
02/19/2013US8377851 Method of altering the alkaloid composition in poppy plants
02/19/2013CA2644881C Demethylation of 14-hydroxy substituted alkaloid derivatives
02/07/2013WO2013019825A1 Stepwise process for the production of alkaloid salts
02/07/2013US20130035489 Preparation of low impurity opiates in a continuous flow reactor
02/07/2013US20130035488 Stepwise Process for the Production of Alkaloid Salts
02/07/2013CA2842370A1 Stepwise process for the production of alkaloid salts
02/06/2013EP2552924A1 Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs
02/05/2013US8367827 Process for preparing hydrocodone using a super acid
02/05/2013US8367693 Opioid salts and formulations exhibiting anti-abuse anti-dose dumping properties
01/2013
01/29/2013US8361499 Controlled release hydrocodone formulations
01/29/2013CA2448665C Sustained-release analgesic compounds
01/24/2013US20130023553 Pegylated opioids with low potential for abuse and side effects
01/23/2013CN102887903A Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
01/22/2013US8357802 Process for preparing oxymorphone
01/17/2013WO2013007986A1 Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 24